BBNX Beta Bionics
Beta Bionics earnings company data as of 1:58 PM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 27 Oct | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by BBNX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- $3M sold by 7 insiders under 10b5-1 plans
-
Mark Hopman Chief Commercial OfficerPlanned sale$13K 775 shares at $17.35 1.4% of stakeTraded Oct 14 Filed Oct 16
-
Mark Hopman Chief Commercial OfficerPlanned sale$7,015 370 shares at $18.96 0.7% of stakeTraded Oct 1 Filed Oct 5
-
Christy Jones DirectorPlanned sale$148K 6,430 shares at $23.00 25% of stakeTraded Sep 22 Filed Sep 23
-
Mark Hopman Chief Commercial OfficerPlanned sale$665K 35,994 shares at $18.46 29% of stakeTraded Sep 9 Filed Sep 18
-
Mike Mensinger Chief Product OfficerPlanned sale$58K 2,650 shares at $22.00 1.5% of stakeTraded Sep 16 Filed Sep 17
-
Mark Hopman Chief Commercial OfficerPlanned sale$620K 30,779 shares at $20.13 35% of stakeTraded Sep 16 Filed Sep 17
-
Mark Hopman Chief Commercial OfficerPlanned sale$12K 775 shares at $15.52 0.9% of stakeTraded Sep 14 Filed Sep 15
-
Sean Saint CEOPlanned sale$113K 5,641 shares at $20.08 1.4% of stakeTraded Sep 3 Filed Sep 4
-
Stephen Feider CFOPlanned sale$170K 10,000 shares at $17.04 5.7% of stakeTraded Jun 26–29 Filed Jul 2
-
Mark Hopman Chief Commercial OfficerPlanned sale$19K 1,258 shares at $15.01 1% of stakeTraded Jun 24 Filed Jun 25
-
Christy Jones DirectorPlanned sale$21K 1,406 shares at $15.00 5.1% of stakeTraded Jun 24 Filed Jun 25
-
Mark Hopman Chief Commercial OfficerPlanned sale$3,385 275 shares at $12.31 0.2% of stakeTraded Jun 4 Filed Jun 5
-
Christy Jones DirectorPlanned sale$39K 2,811 shares at $14.00 9.3% of stakeTraded Jun 4 Filed Jun 5
-
Christy Jones DirectorPlanned sale$20K 1,998 shares at $9.95 13% of stakeTraded May 21 Filed May 26
-
Adam Lezack DirectorPlanned sale$21K 1,998 shares at $10.58Traded May 21–22 Filed May 26
Also filed in the last 12 months, not counted as buying or selling: 20 sales to cover taxes, 17 stock grants, and 3 option exercises.
SEC filings
Recent issuer filings from EDGAR, 9 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.